Tags: pfizer | biontech | omicron | fda | covid vaccine

Pfizer Asks FDA to Authorize Omicron Vaccine

Pfizer Asks FDA to Authorize Omicron Vaccine
(AP)

Monday, 22 August 2022 10:54 AM EDT

Pfizer Inc and partner BioNTech said on Monday they had completed a submission to the U.S. Food and Drug Administration for authorization of a COVID-19 vaccine adapted to target the omicron variant.

The request was for a so-called bivalent vaccine that contains the dominant BA.4/BA.5 variants of the virus, along with the original coronavirus strain.

The FDA in June asked COVID-19 vaccine makers to tailor shots to target the two subvariants.

The U.S. government has since signed a deal with both Moderna and Pfizer for delivery of omicron-adapted vaccines, pending clearance.

© 2025 Thomson/Reuters. All rights reserved.


StreetTalk
Pfizer Inc and partner BioNTech said on Monday they had completed a submission to the U.S. Food and Drug Administration for authorization of a COVID-19 vaccine adapted to target the omicron variant.
pfizer, biontech, omicron, fda, covid vaccine
91
2022-54-22
Monday, 22 August 2022 10:54 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved